STOCK TITAN
  1. Home
  2. Sec-filings
  3. DRDGF
  4. [Form 4] DRDGOLD LTD Insider Trading Activity

DRDGOLD officer sells 20,060 shares at $2.75

An executive at DRDGOLD settles 20,060 vested deferred shares into ordinary shares and then sells the same number in a pooled transaction.

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

DRDGOLD LTD (DRD) reported that Dean Lindecke, General Manager Ergo Ops., had 20,060 deferred shares granted under the Company’s Single Incentive Plan vest on August 13, 2026 and settle one-for-one into Ordinary Shares for no consideration.

Following this vesting, 20,060 Ordinary Shares were sold on the reporting person’s behalf in a pooled sale conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share, translated from an average sale price of ZAR 44.4764 per share. After these transactions, the reporting person held 94,415 deferred shares, with no Rule 10b5-1 trading plan reported.

Positive

  • None.

Negative

  • None.
Insider Lindecke Dean
Role General Manager Ergo Ops.
Sold 20,060 shs ($55K)
Approx. gross sale proceeds $55K
Approx. exercise cost $0.00
Type Security Shares Price Value
Sale Ordinary Shares F2, F3 20,060 $2.7545 $55K
Exercise Deferred Shares F1, F4 20,060 $0.00 $0.00
Grant/Award Ordinary Shares F1 20,060 $0.00 $0.00
Holdings After Transaction: Deferred Shares — 94,415 contracts (Direct); Ordinary Shares — 0 shares (Direct)
Footnotes (4)
  1. F1. On August 13, 2026, 20,060 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
  2. F2. Represents 20,060 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 20,060 Deferred Shares described in footnote 1.
  3. F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
  4. F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.
Ordinary Shares sold 20,060 shares Pooled sale conducted on August 31 and September 1, 2026
Average sale price (USD) $2.7545 per share Converted from ZAR using South African Reserve Bank rate on transaction dates
Average sale price (ZAR) ZAR 44.4764 per share Average sale price for Ordinary Shares sold in pooled transaction
Deferred shares vested and settled 20,060 shares Deferred Shares vested and settled into Ordinary Shares on August 13, 2026
Deferred shares held after transaction 94,415 shares Reported current holdings of Deferred Shares after subsequent acquisition noted in Table II
Single Incentive Plan financial
"previously awarded to the Reporting Person under the Company's Single Incentive Plan"
Deferred Shares financial
"20,060 deferred shares of DRDGOLD Limited (the "Company") previously awarded"
Deferred shares are a class of stock whose economic benefits or certain shareholder rights are delayed or paid later than ordinary shares—for example, dividends may be paid only after other shareholders receive theirs, or voting or redemption rights may be postponed. For investors, that timing difference matters because deferred shares typically offer lower near-term income and different risk, affecting expected returns, priority in payouts, and the share’s market value; think of them like a delayed paycheck compared with a regular salary.
pooled sale financial
"sold on behalf of the Reporting Person as part of a pooled sale conducted"
South African Reserve Bank financial
"converted from ZAR using the South African Reserve Bank exchange rate"

FAQ

What insider transactions did DRD report for Dean Lindecke in this Form 4?
DRD reported that on August 13, 2026, 20,060 deferred shares vested and settled into Ordinary Shares for no consideration, and that 20,060 Ordinary Shares were later sold on August 31 and September 1, 2026 in a pooled transaction.

How many DRD shares did the insider sell and at what price?
The insider had 20,060 Ordinary Shares sold in a pooled sale on August 31 and September 1, 2026 at an average price of $2.7545 per share, based on conversion from an average sale price of ZAR 44.4764 per share.

What happened to the deferred shares reported by DRD for this insider?
On August 13, 2026, 20,060 deferred shares previously awarded under DRDGOLD’s Single Incentive Plan vested and were settled one-for-one into Ordinary Shares for no consideration. After these events, the insider held 94,415 deferred shares according to the filing.

Were Dean Lindecke’s DRD share sales under a Rule 10b5-1 trading plan?
No. The filing states the Rule 10b5-1 checkbox is not affirmed, and there is no footnote indicating a trading plan, so these transactions are not reported as being made under a Rule 10b5-1 plan.

What role does the reporting person hold at DRDGOLD (DRD)?
The reporting person, Dean Lindecke, is identified as an officer of DRDGOLD Limited with the title General Manager Ergo Ops. in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lindecke Dean
(Last)(First)(Middle)
CYCAD HOUSE, BUILDING 17, GROUND FLOOR
CNR 14TH AVENUE AND HENDRIK POTGIETER RD
(Street)
WELTEVREDEN PARK1709
(City)(State)(Zip)
SOUTH AFRICA
(Country)		2. Issuer Name and Ticker or Trading Symbol
DRDGOLD LTD [ DRD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Manager Ergo Ops.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares08/13/2026A20,060(1)A$020,060D
Ordinary Shares09/01/2026S20,060(2)D$2.7545(3)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Shares$008/13/2026M20,060(1) (1) (1)Ordinary Shares20,060$094,415(4)D
Explanation of Responses:
1. On August 13, 2026, 20,060 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
2. Represents 20,060 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 20,060 Deferred Shares described in footnote 1.
3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.
Remarks:
/s/ Dean Lindecke09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR